Composition for silicone rubber material

A curable silicone composition using a heterocyclic azasilane and organic phosphonic acid addresses storage stability and adhesion issues in silicone rubber compounds, enhancing stability and adhesion without toxic tin catalysts, maintaining mechanical properties and transparency.

JP2024541613AActive Publication Date: 2024-11-08NITROCHEM ASCHAU
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2024532406
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-11-30
Filing Date
2022-11-24
Publication Date
2024-11-08
Estimated Expiration
2042-11-24

AI Technical Summary

Technical Problem

Existing silicone rubber compounds face issues with storage stability and adhesion to various substrates, particularly when using tin-containing catalysts, which are also toxic.

Method used

A curable composition comprising a polyorganosiloxane, a crosslinking agent with a suitable leaving group, and a heterocyclic azasilane, combined with an organic phosphonic acid, which reacts with atmospheric moisture to initiate crosslinking, enhancing storage stability and adhesion without the use of toxic tin catalysts.

Benefits of technology

The composition exhibits improved storage stability and adhesion to diverse substrates while maintaining cure properties, offering transparent appearance and mechanical integrity, with reduced toxicity and equivalent mechanical properties compared to traditional compositions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024541613000001
    Figure 2024541613000001
  • Figure 2024541613000002
    Figure 2024541613000002
  • Figure 2024541613000003
    Figure 2024541613000003
Patent Text Reader

Abstract

The present invention relates to a curable composition comprising a polyorganosiloxane, a silane-based crosslinker, a heterocyclic azasilane and an organic phosphonic acid. The present invention also relates to a process for producing the curable composition and its use.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a curable composition comprising a polyorganosiloxane, a crosslinker having a suitable leaving group and a heterocyclic azasilane, a process for preparing the curable composition and its use as a sealant, glue, coating, joint material, potting resin, adhesive and in coatings.

[0002] Silicone rubber compounds are materials with elastic properties and have a wide range of applications, especially in the public health sector and in building construction, as sealants, joints, coatings, potting compounds and adhesives for a wide variety of materials, such as glass, porcelain, ceramics, stone, plastics, metals, wood, etc. RTV (ambient temperature cure) silicone rubber compounds, especially low temperature cure silicone rubber compounds, also known as single-component RTV silicone rubber compounds (RTV-1), are frequently used. These silicone rubber compounds are usually plastically deformable mixtures of polyorganosiloxanes with crosslinkable functional groups and suitable crosslinkers (hardeners) and are stored in a moisture-free environment. These mixtures crosslink at room temperature under the influence of water or moisture. This process is known as curing. Adhesion promoters are also commonly used in silicone rubber compounds. They are used in silicone rubber compounds (e.g. sealants or adhesives) to ensure good adhesion to various substrates.

[0003] In low-temperature curing silicone rubber compounds, polyorganosiloxanes (silicones) with two or more crosslinkable functional groups are commonly used together with multifunctional curing agents. Here, α,ω-dihydroxy polyorganosiloxanes are of great importance as difunctional polyorganosiloxanes. The crosslinking or curing agents often have hydrolyzable SiX groups, and depending on the leaving group liberated by hydrolysis, the curing agents can be classified as acidic, neutral or basic. Well-known leaving groups are, for example, carboxylic acids, alcohols and oximes.

[0004] The curing, crosslinking or polymerization of RTV-1 silicone rubber compounds can be further accelerated by adding suitable catalysts, where tin compounds have proven to be advantageous catalysts due to their high catalytic activity.

[0005] DE 10 2015 204 787 A1 describes a curable silicone rubber compound, which contains at least one polyorganosiloxane having at least one hydroxyl group bonded to silicon atom, at least one silane, aminosilane and tin compound as catalyst.However, tin compound, especially commonly used alkyltin compound, has the disadvantage that it is toxic.In addition, storage stability and adhesion to a wide range of substrates still need to be improved.

[0006] EP 3 392 313 A1 describes a curable silicone rubber compound that contains a silicone compound with two terminal hydroxyl groups, a catalyst that contains a metal-siloxane-silanol (at) compound, and a crosslinker that contains a silane with a corresponding leaving group.In particular, the catalyst can be tin-free.However, the storage stability and adhesion to various substrates still need to be improved.

[0007] EP 3 613 803 A1 describes a composition for silicone rubber compounds, which comprises a curing agent in the form of a silane having a corresponding leaving group and at least one heterocyclic organosilane.

[0008] Although the above-mentioned compositions are RTV-1 silicone rubber compounds that cure at room temperature in the presence of atmospheric moisture, the storage stability and adhesion to various substrates of these compositions still need to be improved.

[0009] Therefore, an object of the present invention is to overcome these drawbacks and to provide a silicone rubber-based composition that cures at room temperature, has high storage stability, and exhibits good adhesion to any common material or substrate.

[0010] This object is solved by a composition as defined in claim 1, a method as defined in claim 14 and a use as defined in claim 15. Advantageous embodiments can be found, inter alia, in the subclaims and are explained in more detail below.

[0011] In one embodiment, the composition of the present invention comprises: (a) Formula HO-(SiR l R m O) o -H[in the formula, Each R l and R m are, independently, optionally substituted alkyl, alkenyl or alkynyl residues; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue; and o is an integer from 5 to 5000. A polyorganosiloxane represented by the formula: (b) Formula Si(R) m (R a ) 4-m [In the formula, Each R is independently optionally substituted alkyl, alkenyl or alkynyl residues; an optionally substituted alicyclic, aryl or aralkyl residue; or an optionally substituted heteroalicyclic or heteroaryl residue; m is an integer from 0 to 2; Each R a are, independently, (b1) Formula (I): [ka] (In the formula, Each R b and R c are, independently of each other, hydrogen; optionally substituted alkyl, alkenyl or alkynyl residues; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue; Each R d are, independently, optionally substituted alkyl, alkenyl or alkynyl residues; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue; Each R e are, independently, carbon; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue; and n is an integer from 1 to 10. A hydroxycarboxylic acid ester residue represented by the formula: (b2) Formula (II): [ka] (In the formula, Each R n , R o , R p and R q are, independently of each other, hydrogen; optionally substituted alkyl, alkenyl or alkynyl residues; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue; R r are, independently of each other, carbon; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue; and p is an integer from 1 to 10. a hydroxycarboxylic acid amide residue having the formula (b3) Carboxylic acid residue -OC(O)-R f , (b4) Oxime residue -ON=CR g R h , and (b5) Carboxylic acid amide residue -N(R i )-C(O)-R j (In the formula, Each R f , R g , R h , R i and R j are, independently of each other, hydrogen; optionally substituted alkyl, alkenyl or alkynyl residues; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue selected from the group consisting of A crosslinking agent having (c) heterocyclic azasilanes, in which N and Si are ring atoms and are directly linked to each other; and (d) Formula R-PO(OH)2 [wherein, R is optionally substituted alkyl, alkenyl or alkynyl residues, an optionally substituted alicyclic, aryl or aralkyl residue, or an optionally substituted heteroalicyclic or heteroaryl residue. The organic phosphonic acid includes an organic phosphonic acid represented by the formula:

[0012] Surprisingly, the compositions exhibit improved storage stability and improved adhesion to a variety of plastics, where other essential properties of a curable composition, in particular through-cure, tack-free time, full cure, clear appearance, Shore A hardness and adhesion to a variety of other substrates, are not adversely affected.

[0013] The heterocyclic azasilane in the curable composition according to the present invention has an advantage over conventional aminosilanes in the corresponding silicone rubber compounds in that it only opens the ring in the presence of atmospheric moisture, i.e. only then does the curable composition crosslink, thereby resulting in reactive aminosilanes. In this way, the reaction of the aminosilane with the crosslinker and other components of the curable composition is avoided at a point before they are exposed to atmospheric moisture. This enhances storage stability. Surprisingly, it has been found that the combination of the heterocyclic azasilane with an organic phosphonic acid, in particular an alkylphosphonic acid, leads to a further significant improvement in storage stability. Surprisingly, this is especially true when using crosslinkers that contain, for example, hydroxycarboxylic acid ester residues or hydroxycarboxylic acid amide residues, and is particularly relevant for these crosslinkers, since they contain reactive leaving groups (particularly more reactive than alkoxysilanes that contain alkoxy groups as leaving groups), which generally lead to poor storage stability due to the reactive leaving groups.

[0014] For the purposes of the present invention, "crosslinker" or "hardener" is understood to mean in particular a crosslinkable silane compound having at least two groups that can be cleaved off by hydrolysis. Examples of such crosslinkable silane compounds are Si(OCH3)4, Si(CH3)(OCH3)3 and Si(CH3)(C2H5)(OCH3)2. Crosslinkers can also be called hardeners. "Crosslinker" also includes in particular a "crosslinker system" that can contain multiple crosslinkable silane compounds.

[0015] "Sealant", "sealant" or "sealing compound" refers to a resilient substance that is applied in liquid to viscous form or as flexible profiles or sheets to seal surfaces, especially against water, gas or other media.

[0016] The term "adhesive" refers to a substance that bonds parts by surface adhesion (adhesion) and / or internal strength (cohesion). The term includes glue adhesives, paste adhesives, dispersion adhesives, solvent adhesives, reactive adhesives and contact adhesives, among others.

[0017] "Coating agent" means any agent used to coat a surface.

[0018] In the context of the present invention, a "potting compound" or "cable potting compound" is a high- or low-temperature processable compound for potting cables and / or cable accessories.

[0019] The term "alkyl group" refers to a saturated hydrocarbon residue. In particular, an alkyl group has the formula -C n H 2n+1 The term "C1-C16 alkyl group" refers in particular to a saturated hydrocarbon chain having 1 to 16 carbon atoms in the chain. Examples of alkyl groups are methyl, ethyl, propyl, butyl, isopropyl, iso-butyl, sec-butyl, tert-butyl, n-pentyl and ethylhexyl. In particular, alkyl groups may also be substituted, even if not explicitly stated.

[0020] A "straight chain alkyl group" refers to an alkyl group that does not contain a branched chain. Examples of straight chain alkyl groups are methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, and n-octyl.

[0021] "Branched alkyl group" refers to an alkyl group that is not linear, i.e., the hydrocarbon chain has a particular branch. Examples of branched alkyl groups are isopropyl, iso-butyl, sec-butyl, tert-butyl, sec-pentyl, 3-pentyl, 2-methylbutyl, iso-pentyl, 3-methylbut-2-yl, 2-methylbut-2-yl, neopentyl, ethylhexyl, and 2-ethylhexyl.

[0022] The term "alkenyl group" refers to a hydrocarbon residue containing at least one double bond. For example, an alkenyl group having a double bond is, inter alia, of the formula -C n H 2n-1 However, alkenyl groups can also have multiple double bonds. The term "C2-C16 alkenyl group" specifically refers to a hydrocarbon chain having 2 to 16 carbon atoms in the chain. The number of hydrogen atoms varies according to the number of double bonds in the alkenyl group. Examples of alkenyl groups are vinyl, allyl, 2-butenyl and 2-hexenyl.

[0023] A "straight chain alkenyl group" refers to an alkenyl group that does not contain any branched chains. Examples of straight chain alkenyl groups are vinyl, allyl, n-2-butenyl, and n-2-hexenyl.

[0024] "Branched alkenyl group" refers to an alkenyl group that is not linear, i.e., the hydrocarbon chain has a particular branch. Examples of branched alkenyl groups are 2-methyl-2-propenyl-, 2-methyl-2-butenyl- and 2-ethyl-2-pentenyl-.

[0025] The term "alkynyl group" refers to a hydrocarbon residue containing at least one triple bond. For example, an alkynyl group having a triple bond can be represented by the formula -C n H 2n-3 Alkynyl groups can also contain multiple triple bonds. In addition, double and triple bonds can be present. Examples are ethynyl, propynyl, butynyl or pentynyl. Alkynyl groups can be substituted or unsubstituted.

[0026] The term "aryl group" refers to a mono- or polycyclic aromatic residue. "Aromatic" refers to a cyclic planar hydrocarbon having a conjugated aromatic π-electron system. Aryl groups are, for example, monocyclic (e.g., phenyl), bicyclic (e.g., indenyl, naphthalenyl, tetrahydronaphthyl or tetrahydroindenyl) and tricyclic (e.g., fluorenyl, tetrahydroindenyl, fluorenyl, tetrahydrofluorenyl, anthracenyl or tetrahydroanthracenyl) ring systems, in which at least one of the rings in the monocyclic ring system or the bicyclic or tricyclic ring system is aromatic. In particular, a C4-C14 aryl group represents an aryl group having 4 to 14 carbon atoms. In particular, the aryl group may also be substituted, even if not explicitly stated.

[0027] Aromatic groups can be monocyclic, bicyclic, tricyclic or polycyclic. Aromatic groups can also contain 1 to 5 heteroatoms selected from the group consisting of N, O and S. These groups are also referred to as heteroaryl groups (see below). Examples of aromatic groups are benzene, naphthalene, anthracene, phenanthrene, furan, pyrrole, thiophene, isoxazole, pyridine and quinoline, with the necessary number of hydrogen atoms removed from any of the above examples to allow incorporation into the corresponding structural formula.

[0028] A "cycloalkyl group" or an "alicyclic residue" refers to a mono- or polycyclic hydrocarbon residue that is not aromatic. In particular, a cycloalkyl group having 4 to 14 carbon atoms refers to a non-aromatic hydrocarbon ring having 4 to 14 carbon atoms. The cycloalkyl group may be saturated or partially unsaturated. A saturated cycloalkyl group is not aromatic and has no double or triple bonds. In contrast to a saturated cycloalkyl group, a partially unsaturated cycloalkyl group has at least one double or triple bond and the cycloalkyl group is not aromatic. In particular, the cycloalkyl group may also be substituted, even if not specifically indicated.

[0029] An "aralkyl group" refers to an alkyl group substituted with an aryl group. A "C5-C15 aralkyl group" refers specifically to an aralkyl group having 5 to 15 carbon atoms, in which both the alkyl and aryl carbon atoms are contained. Examples of aralkyl groups are benzyl and phenylethyl. In particular, an aralkyl group may also be substituted, even if not specifically indicated.

[0030] "Cyclic ring system" refers to a non-aromatic hydrocarbon ring. In particular, a cyclic ring system having 4 to 14 carbon atoms refers to a non-aromatic hydrocarbon ring system having 4 to 14 carbon atoms. A cyclic ring system may consist of a single hydrocarbon ring (monocyclic), two hydrocarbon rings (bicyclic) or three hydrocarbon rings (tricyclic). In particular, a cyclic ring system may also contain 1 to 5 heteroatoms, preferably selected from the group consisting of N, O and S.

[0031] A "saturated cyclic ring system" is not aromatic and has no double or triple bonds. Examples of saturated cyclic ring systems are cyclopentane, cyclohexane, decalin, norbornane and 4H-pyran, in each of the preceding cases where the necessary number of hydrogen atoms have been removed to allow incorporation into the corresponding structural formula. For example, the structural formula HO-R * -CH3(wherein, R *is a cyclic ring system having 6 carbon atoms, particularly cyclohexane), two hydrogen atoms would be removed from the cyclic ring system, particularly from cyclohexane, to allow incorporation into the structural formula.

[0032] A "heteroaryl" group, as used herein, specifically refers to a monocyclic or polycyclic aromatic ring of 5 to 10 ring atoms, in which 1, 2, 3, or 4 ring atoms are nitrogen, oxygen, or sulfur, and the remainder are carbon. Heteroaryl groups may be substituted or unsubstituted. When they are substituted, the substituents are as defined for cycloalkyl above.

[0033] "Heteroalicyclic residue" or "heterocycloalkyl group" as used herein means a monocyclic or fused ring of 5 to 10 ring atoms containing 1, 2 or 3 heteroatoms selected from N, O and S, with the remaining ring atoms being carbon. "Heterocycloalkenyl" groups also contain one or more double bonds. However, the ring does not have a completely conjugated pi-electron system. If substituted, the substituents are as defined for cycloalkyl above.

[0034] Unless otherwise specified, N specifically represents nitrogen. Furthermore, unless otherwise specified, O specifically represents oxygen. Unless otherwise specified, S specifically represents sulfur and Si specifically represents silicon.

[0035] "Optionally substituted" means that a hydrogen atom in the corresponding group or in the corresponding residue may be replaced by a substituent. In particular, the substituent may be selected from the group consisting of C1-C4 alkyl, methyl, ethyl, propyl, butyl, phenyl, benzyl, halogen, fluorine, chlorine, bromine, iodine, hydroxyl, amino, alkylamino, dialkylamino, C1-C4 alkoxy, phenoxy, benzyloxy, cyano, nitro and thio. When a group is specified as being optionally substituted, 0-50, in particular 0-20, hydrogen atoms of the group may be replaced by a substituent. When a group is substituted, at least one hydrogen atom is replaced by a substituent.

[0036] "Alkoxy" refers to an alkyl group linked to the main carbon chain through an oxygen atom.

[0037] Within the meaning of the present invention, heterocyclic azasilanes are understood to be cyclic organic compounds that contain silicon and nitrogen atoms as ring atoms, respectively. In particular, they can be 3- to 12-membered rings, preferably 5- or 6-membered rings, particularly preferably 5-membered rings. In the heterocyclic azasilanes of the present invention, Si and N are directly linked to each other. Such cyclic or heterocyclic azasilanes are not aminosilanes, but are also called heterocyclic aminosilanes, since the corresponding aminosilanes are formed only through ring opening from heterocyclic azasilanes with adjacent Si and N atoms by reaction with water.

[0038] The term "polysiloxane" or "polyorganosiloxane" refers to an organic silicone compound. The polyorganosiloxane contained in the composition is an α,ω-dihydroxyl-terminated polyorganosiloxane. In addition to homopolymeric α,ω-dihydroxyl-terminated polydiorganosiloxanes, heteropolymeric α,ω-dihydroxyl-terminated polydiorganosiloxanes with different organic substituents can also be used, including copolymers of monomers with similar organic substituents on the silicon atom as well as copolymers of monomers with different organic substituents on the silicon atom, such as those with mixed alkyl, alkenyl and / or aryl substituents. Preferred organic substituents include linear and branched alkyl groups having 1 to 8 carbon atoms, in particular methyl, ethyl, n- and iso-propyl, n-, sec- and tert-butyl, vinyl and phenyl. In each organic substituent, individual or all of the hydrogen atoms bonded to the carbons may be replaced by conventional substituents, such as halogen atoms or functional groups such as hydroxyl and / or amino groups. For example, α,ω-dihydroxyl terminated polydiorganosiloxanes having partially or fully fluorinated organic substituents can be used, or α,ω-dihydroxyl terminated polydiorganosiloxanes in which the organic substituents on the silicon atoms are substituted with hydroxyl and / or amino groups are used.

[0039] Preferred examples of the organosilicone compound are α,ω-dihydroxyl-terminated polydialkylsiloxanes, such as α,ω-dihydroxyl-terminated polydimethylsiloxane, α,ω-dihydroxyl-terminated polydiethylsiloxane or α,ω-dihydroxyl-terminated polydivinylsiloxane, and α,ω-dihydroxyl-terminated polydiarylsiloxanes, such as α,ω-dihydroxyl-terminated polydiphenylsiloxane. Polyorganosiloxanes having a kinematic viscosity of 5,000 to 120,000 cSt (at 25°C), particularly those having a viscosity of 20,000 to 100,000 cSt, particularly preferably those having a viscosity of 40,000 to 90,000 cSt, are preferred. Mixtures of polydiorganosiloxanes having different viscosities can also be used.

[0040] The terms "material" or "sealant" as used herein describe the cured composition of the present invention.

[0041] For the purposes of the present invention, "silicone rubber compounds" are synthetic silicone-containing rubber compounds, also interchangeably called curable silicone compositions in the context of the present invention, including rubber polymers, polycondensates and polyadducts that can be converted to a highly elastic cured state by crosslinking with a suitable crosslinking agent. Moreover, they are plastically deformable mixtures of, for example, α,ω-dihydroxy polyorganosiloxanes with suitable curing or crosslinking agents that can be stored under the exclusion of moisture, and these silicone rubber compounds polymerize at room temperature under the influence of water or atmospheric moisture.

[0042] The term "catalyst" refers to a substance that lowers the activation energy of a particular reaction, thereby increasing the rate of the reaction.

[0043] The composition has the formula HO-(SiR l R m O) o -H and compounds with the formula Si(R) m (R a ) 4-mThe crosslinker may be in the form of a prepolymer, which is the reaction product of the two components. These reactions are known and are also called end-capping, as described, for example, in WO 2016 / 146648 A1.

[0044] "Tensile strength" is one of the mechanical properties of a polymer that can be determined using various test methods. "Tensile strength" can be determined by the tensile stress at the moment when a test specimen breaks in a tensile test.

[0045] "Elongation at break" is the ratio of the change in length to the initial length after a test specimen breaks. It describes the ability of a material to withstand a change in shape without cracking. The elongation at break is determined in tensile tests according to DIN EN ISO 8339 and DIN 53504.

[0046] "Elongation stress value" defines the stress that the sealant exerts on the attached surface or adjacent building material when elongated by 100%.

[0047] "Secant modulus" is the ratio of stress to strain at any point on the curve of a stress-strain diagram. It is the slope of the curve from the beginning to any point on the stress-strain curve.

[0048] "Elastic recovery" describes the tendency of a flexible beam to fully or partially return to its original size after the force that caused the elongation or deformation has been removed. The average elastic recovery is determined in accordance with DIN EN ISO 7389.

[0049] In a preferred embodiment of the present invention, the curable composition comprises (a) Formula HO-(SiR l R m O) o -H[wherein, R l and R m is as defined above, and o is an integer from 5 to 5000. At least one compound represented by (b) Formula Si(R)m (R a ) 4-m [In the formula, each R is independently an optionally substituted straight or branched chain C1-C16 alkyl group, an optionally substituted straight or branched chain C2-C16 alkenyl group, or an optionally substituted C4-C14 aryl group; m is an integer from 0 to 2; Each R a are, independently, - Formula (I): [ka] (In the formula, Each R b are independently H, or an optionally substituted straight or branched chain C1-C16 alkyl group, or an optionally substituted C4-C14 aryl group; Each R c are independently H, or an optionally substituted straight or branched chain C1-C16 alkyl group, or an optionally substituted C4-C14 aryl group; R d is an optionally substituted straight or branched chain C1-C16 alkyl group, an optionally substituted straight or branched chain C2-C16 alkenyl or alkynyl group, an optionally substituted C4-C14 cycloalkyl or cycloalkenyl group, an optionally substituted C5-C15 aralkyl group, or an optionally substituted C4-C14 aryl group; R e is C or an optionally substituted saturated or partially unsaturated cyclic ring system having 4 to 14 C atoms or an optionally substituted aromatic group having 4 to 14 C atoms, and n is an integer from 1 to 10. a hydroxycarboxylic acid ester residue having -Formula (II): [ka] (In the formula, Each R n are independently H, or an optionally substituted straight or branched chain C1-C16 alkyl group, or an optionally substituted C4-C14 aryl group; Each R o are independently H, or an optionally substituted straight or branched chain C1-C16 alkyl group, or an optionally substituted C4-C14 aryl group; R p and R q are, independently of each other, H, or an optionally substituted linear or branched C1-C16 alkyl group, an optionally substituted C4-C14 cycloalkyl group, an optionally substituted C5-C15 aralkyl group, or an optionally substituted C4-C14 aryl group; R r is C or an optionally substituted saturated or partially unsaturated cyclic ring system having 4 to 14 C atoms or an optionally substituted aromatic group having 4 to 14 C atoms, and p is an integer from 1 to 10. a hydroxycarboxylic acid amide residue having the formula -Carboxylic acid residue -OC(O)-R f (In the formula, R f is H, or an optionally substituted straight or branched chain C1-C16 alkyl group, an optionally substituted C4-C14 cycloalkyl group, an optionally substituted C4-C14 aryl group, or an optionally substituted C5-C15 aralkyl group. -Oxime residue -ON=CR g R h (In the formula, R g and R h are each independently H, or an optionally substituted straight or branched C1-C16 alkyl group, an optionally substituted C4-C14 cycloalkyl group, or an optionally substituted C4-C14 aryl group, or an optionally substituted C5-C15 aralkyl group, and -Carboxylic acid amide residue -N(R i )-C(O)-R j (In the formula, R i is H, or an optionally substituted linear or branched C1-C16 alkyl group, an optionally substituted C4-C14 cycloalkyl group, or an optionally substituted C4-C14 aryl group, or an optionally substituted C5-C15 aralkyl group; R j is H, or an optionally substituted straight or branched chain C1-C16 alkyl group, an optionally substituted C4-C14 cycloalkyl group, an optionally substituted C4-C14 aryl group, or an optionally substituted C5-C15 aralkyl group. selected from the group consisting of At least one crosslinker having (c) heterocyclic azasilanes, in which N and Si are ring atoms and are directly linked to each other; and (d) Formula R-PO(OH)2 [wherein, R is optionally substituted alkyl, alkenyl or alkynyl residues, an optionally substituted alicyclic, aryl or aralkyl residue, or an optionally substituted heteroalicyclic or heteroaryl residue. The organic phosphonic acid includes an organic phosphonic acid represented by the formula:

[0050] The amount of the organic phosphonic acid relative to the total amount of the crosslinking agent is preferably 0.3 to 30 mol %, particularly preferably 1 to 10 mol %, further preferably 3 to 8 mol %, and most preferably 5 to 7 mol %.

[0051] The molar ratio of the crosslinking agent to the organic phosphonic acid is preferably 3 to 350, more preferably 5 to 120, and most preferably 10 to 20. The amount of the organic phosphonic acid based on the total amount of the heterocyclic azasilane is preferably 1 to 30 mol%, more preferably 3 to 25 mol%, and most preferably 8 to 18 mol%.

[0052] In the organic phosphonic acid represented by the formula R-PO(OH)2, R is preferably optionally substituted alkyl, alkenyl or alkynyl residues, in each case having 2 to 12 carbon atoms; It represents an optionally substituted alicyclic, aryl or aralkyl residue, in each case having 6 to 12 carbon atoms, or an optionally substituted heteroalicyclic or heteroaryl residue, in each case having 6 to 12 carbon atoms.

[0053] The organic phosphonic acid is further preferably an alkylphosphonic acid, where the alkyl residue has 2 to 12 carbon atoms, preferably 4 to 10 carbon atoms, more preferably 6 to 9 carbon atoms, most preferably 8 carbon atoms. The alkyl residue may be substituted or unsubstituted, preferably unsubstituted, and / or it may be branched or unbranched, preferably unbranched. The organic phosphonic acid is most preferably octylphosphonic acid, in particular n-octylphosphonic acid.

[0054] Formula HO-(SiR l R m O) o The compound represented by -H is Each R l and R m But independently, optionally substituted alkyl, alkenyl or alkynyl residues; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue; and Silicone compounds, also known as polyorganosiloxanes, in which o is an integer from 5 to 5,000.

[0055] In a preferred embodiment, each R l and R mindependently represent an optionally substituted straight or branched chain C1 to C16 alkyl group, an optionally substituted straight or branched chain C2 to C16 alkenyl group, or an optionally substituted C4 to C14 aryl group.

[0056] In a further preferred embodiment, the polyorganosiloxane HO-(SiR l R m O) o In -H, o is an integer of 5 to 3,500, more preferably 10 to 3,500, even more preferably 100 to 3,000, particularly preferably 800 to 2,000, and most preferably 1,000 to 1,800.

[0057] In a further embodiment, the polyorganosiloxane HO-(SiR l R m O) o -H is a weight average molecular weight M of 400 to 5,000,000, in particular 3,000 to 2,500,000, 15,000 to 1,000,000, 30,000 to 750,000, 50,000 to 500,000 or 110,000 to 150,000; w has.

[0058] The composition also comprises a polyorganosiloxane HO-(SiR l R m O) o -Regarding H.

[0059] In a preferred embodiment, a polyorganosiloxane HO-(SiR l R m O) o -H has a kinematic viscosity at 25°C of 20 to 350,000 cSt, or 20,000 to 100,000 cSt, or 20,000 to 90,000 cSt, or 20,000 to 80,000 cSt.

[0060] In a further preferred embodiment, the composition comprises R l and R mwhich independently of one another contain an optionally substituted linear or branched C1-C16 alkyl group, in particular an optionally substituted linear or branched C1-C12 or C1-C8 alkyl group, an optionally substituted linear or branched C2-C16 alkenyl group, in particular an optionally substituted linear or branched C2-C12 or C2-C8 alkenyl group, or an optionally substituted C4-C14 aryl group, in particular an optionally substituted C4-C10 aryl group. l R m O) contains oH.

[0061] In a particularly preferred embodiment, the composition according to the invention comprises R l and R m is independently selected from the group consisting of methyl-, ethyl-, propyl-, butyl-, trifluoromethyl-, vinyl-, allyl-, butenyl-, phenyl- and -naphthyl-; l R m O) o -H included.

[0062] In a particularly preferred embodiment, the composition according to the invention comprises a polyorganosiloxane HO-(SiR l R m O) o -H included.

[0063] Furthermore, the composition according to the present invention may be a But independently, Formula (I): [ka] a hydroxycarboxylic acid ester residue having ·Formula (II): [ka] a hydroxycarboxylic acid amide residue having the formula Carboxylic acid residue -OC(O)-R f , Oxime residue -ON=CR g R h , Carboxylic acid amide residue -N(R i )-C(O)-R j Formula Si(R) m (R a ) 4-m The crosslinking agent includes a crosslinking agent represented by the formula:

[0064] In a preferred embodiment, the crosslinker has the formula Si(R) m (R a ) 4-m and each residue R independently comprises an optionally substituted straight or branched chain C1-C12 alkyl group, in particular an optionally substituted straight or branched chain C1-C8 alkyl group, or an optionally substituted straight or branched chain C2-C12 alkenyl group, in particular an optionally substituted straight or branched chain C2-C8 alkenyl group, or an optionally substituted C4-C10 aryl group.

[0065] In a particularly preferred embodiment, the formula Si(R) m (R a ) 4-m Each residue R of the crosslinker represented by is independently a methyl, ethyl, propyl, vinyl-, phenyl or allyl residue.

[0066] In a preferred embodiment, the composition according to the invention comprises each R a But independently, Formula (I): [ka] a hydroxycarboxylic acid ester residue having ·Formula (II): [ka] a hydroxycarboxylic acid amide residue having the formula Carboxylic acid residue -OC(O)-R f , Oxime residue -ON=CR g R h , Carboxylic acid amide residue -N(R i )-C(O)-R j (In the formula, Each R b are independently H, or an optionally substituted straight or branched chain C1-C16 alkyl group, or an optionally substituted C4-C14 aryl group; Each R c are independently H, or an optionally substituted straight or branched chain C1-C16 alkyl group, or an optionally substituted C4-C14 aryl group; R d is an optionally substituted straight or branched chain C1-C16 alkyl group, an optionally substituted straight or branched chain C2-C16 alkenyl or alkynyl group, an optionally substituted C4-C14 cycloalkyl or cycloalkenyl group, an optionally substituted C5-C15 aralkyl group, or an optionally substituted C4-C14 aryl group; R e is C or an optionally substituted saturated or partially unsaturated cyclic ring system having 4 to 14 C atoms or an optionally substituted aromatic group having 4 to 14 C atoms, and n is an integer from 1 to 10; Each R n are independently H, or an optionally substituted straight or branched chain C1-C16 alkyl group, or an optionally substituted C4-C14 aryl group; Each R o are independently H, or an optionally substituted straight or branched chain C1-C16 alkyl group, or an optionally substituted C4-C14 aryl group; R p and Rq are, independently of each other, H, or an optionally substituted linear or branched C1-C16 alkyl group, an optionally substituted C4-C14 cycloalkyl group, an optionally substituted C5-C15 aralkyl group, or an optionally substituted C4-C14 aryl group; R r is C or an optionally substituted saturated or partially unsaturated cyclic ring system having 4 to 14 C atoms or an optionally substituted aromatic group having 4 to 14 C atoms, and p is an integer from 1 to 10; R f is H, or an optionally substituted straight or branched chain C1-C16 alkyl group, an optionally substituted C4-C14 cycloalkyl group, or an optionally substituted C4-C14 aryl group, or an optionally substituted C5-C15 aralkyl group; R g and R h are, independently of each other, H, or an optionally substituted straight or branched chain C1 to C16 alkyl group, an optionally substituted C4 to C14 cycloalkyl group, or an optionally substituted C4 to C14 aryl group, or an optionally substituted C5 to C15 aralkyl group; and R i is H, or an optionally substituted linear or branched C1-C16 alkyl group, an optionally substituted C4-C14 cycloalkyl group, or an optionally substituted C4-C14 aryl group, or an optionally substituted C5-C15 aralkyl group; R j is H, or an optionally substituted straight or branched chain C1-C16 alkyl group, an optionally substituted C4-C14 cycloalkyl group, an optionally substituted C4-C14 aryl group, or an optionally substituted C5-C15 aralkyl group. Formula Si(R) m (R a ) 4-m The crosslinking agent includes a crosslinking agent represented by the formula:

[0067] In a preferred embodiment of the invention, the crosslinker comprises a residue R, each R independently comprising an optionally substituted straight or branched chain C1-C12 alkyl group, in particular an optionally substituted straight or branched chain C1-C8 alkyl group, or an optionally substituted straight or branched chain C2-C12 alkenyl group, in particular an optionally substituted straight or branched chain C2-C8 alkenyl group, or an optionally substituted C4-C10 aryl group.

[0068] In a particularly preferred embodiment, the formula Si(R) m (R a ) 4-m Each residue R of the crosslinker represented by the formula (I) is independently a methyl, ethyl, propyl, vinyl-, phenyl or allyl residue. In the hydroxycarboxylic acid ester residue of the crosslinker, each R b and R c are preferably, independently of one another, an optionally substituted linear or branched C1-C12 alkyl group, in particular an optionally substituted linear or branched C1-C8 alkyl group. The number n is preferably an integer from 1 to 5, in particular from 1 to 3, particularly preferably n=1.

[0069] In a preferred embodiment of the invention, in the hydroxycarboxylic acid ester moiety of the crosslinker, each R b and R c is independently selected from the group consisting of H, methyl, ethyl, propyl, isopropyl, butyl, n-butyl, sec-butyl, iso-butyl and tert-butyl, in particular from the group consisting of H and methyl.

[0070] In the hydroxycarboxylic acid ester residue of the crosslinker, R dis preferably an optionally substituted straight or branched chain C1-C12 alkyl group, in particular an optionally substituted straight or branched chain C1-C8 alkyl group, an optionally substituted straight or branched chain C2-C12 alkenyl or alkynyl group, in particular an optionally substituted straight or branched chain C2-C18 alkenyl group, a C4-C10 cycloalkyl group, a C5-C11 aralkyl group, or a C4-C10 aryl group.

[0071] In a further preferred embodiment of the present invention, the hydroxycarboxylic acid ester residue R of the crosslinker d is selected from the group consisting of phenyl-, tolyl-, naphthyl-, benzyl-, cyclohexyl-, methyl-, ethyl-, propyl-, isopropyl-, butyl-, n-butyl-, sec-butyl-, iso-butyl-, tert-butyl-, pentyl-, n-pentyl-, sec-pentyl-, 3-pentyl-, 2-methylbutyl-, iso-pentyl-, 3-methylbut-2-yl-, 2-methylbut-2-yl-, neopentyl-, hexyl-, heptyl-, octyl-, ethylhexyl-, 2-ethylhexyl- and vinyl-. Methyl-, ethyl- and vinyl- are particularly preferred.

[0072] In a preferred embodiment, the hydroxycarboxylic acid ester moiety of the crosslinker is R e is a divalent benzene residue, or R e C and R b and R c is H or R e C and R b is H and R c is methyl-.

[0073] In a particularly preferred embodiment, the R a is a hydroxycarboxylic acid ester residue, n is an integer from 1 to 5, particularly preferred is n=1 to 3, especially 1. Particularly preferred are the crosslinkers methyl-tris(ethyllactato)silane and / or tetra(ethyllactato)silane.

[0074] In one embodiment, in the hydroxycarboxylic acid amide moiety of the crosslinker in the composition according to the invention, each R n and R o is independently H or an optionally substituted straight or branched chain C1-C12 alkyl group, in particular an optionally substituted straight or branched chain C1-C8 alkyl group.

[0075] In the hydroxycarboxylic acid amide residue of the crosslinker, each R n and R o are preferably selected independently of one another from the group consisting of H, methyl, ethyl-, propyl, isopropyl, butyl, n-butyl, sec-butyl, iso-butyl and tert-butyl, in particular from the group consisting of H and methyl.

[0076] In a further embodiment, in the hydroxycarboxylic acid amide moiety of the crosslinker, R p and R q are independently H or an optionally substituted straight or branched chain C1-C12 alkyl group, in particular an optionally substituted straight or branched chain C1-C8 alkyl group, or an optionally substituted C4-C14 cycloalkyl group, or a C5-C11 aralkyl group, or a C4-C10 aryl group.

[0077] In a preferred embodiment, the hydroxycarboxylic acid amide moiety of the crosslinker is R p and R q is independently selected from the group consisting of H, phenyl, tolyl, naphthyl, benzyl, cyclohexyl, methyl, ethyl, propyl-, isopropyl-, butyl-, n-butyl-, sec-butyl-, iso-butyl-, tert-butyl-, pentyl-, n-pentyl-, sec-pentyl-, 3-pentyl-, 2-methylbutyl-, iso-pentyl-, 3-methylbut-2-yl-, 2-methylbut-2-yl-, neopentyl-, hexyl-, heptyl-, octyl-, ethylhexyl-, and 2-ethylhexyl-.

[0078] In one embodiment, in the hydroxycarboxylic acid amide moiety of the crosslinker, R r is a divalent benzene residue, or R r C and R n and R o is H or R r C and R n is H and R o is methyl-.

[0079] In a further preferred embodiment, p in the hydroxycarboxylic acid amide residue of the crosslinker is an integer of 1 to 5, particularly 1 to 3, with p=1 being particularly preferred.

[0080] In the carboxylic acid residue of the crosslinker of the composition according to the invention, R f is preferably H, or an optionally substituted linear or branched C1-C12 alkyl group, an optionally substituted C4-C10 cycloalkyl group, or an optionally substituted C4-C10 aryl group, or an optionally substituted C5-C11 aralkyl group, in particular H, or an optionally substituted linear or branched C1-C8 alkyl group, an optionally substituted C4-C8 cycloalkyl group, or an optionally substituted C4-C10 aryl group, or an optionally substituted C5-C11 aralkyl group.

[0081] In a preferred embodiment, the carboxylic acid residue R of the crosslinker fis selected from the group consisting of H, phenyl-, tolyl-, naphthyl-, benzyl-, cyclohexyl-, methyl-, ethyl-, propyl-, isopropyl-, butyl-, n-butyl-, sec-butyl-, iso-butyl-, tert-butyl-, pentyl-, n-pentyl-, sec-pentyl-, 3-pentyl-, 2-methylbutyl-, iso-pentyl-, 3-methylbut-2-yl-, 2-methylbut-2-yl-, neopentyl-, hexyl-, heptyl-, octyl-, ethylhexyl-, and 2-ethylhexyl-. In a particularly preferred embodiment, the crosslinker having a carboxylic acid residue is ethyltriacetoxysilane and / or methyltriacetoxysilane and / or propyltriacetoxysilane.

[0082] In a further preferred embodiment, in the oxime moiety of the crosslinker according to the invention, R g and R h are independently H or an optionally substituted straight or branched chain C1-C12 alkyl group, an optionally substituted C4-C10 cycloalkyl group, an optionally substituted C4-C10 aryl group, or an optionally substituted C5-C11 aralkyl group, in particular H or an optionally substituted straight or branched chain C1-C8 alkyl group, an optionally substituted C4-C8 cycloalkyl group, an optionally substituted C4-C10 aryl group, or an optionally substituted C5-C11 aralkyl group.

[0083] In a preferred embodiment, in the oxime moiety of the crosslinker, R g and R hare independently selected from the group consisting of H, phenyl, tolyl, naphthyl, benzyl, cyclohexyl, methyl, ethyl, propyl, isopropyl, butyl-, n-butyl-, sec-butyl-, iso-butyl-, tert-butyl-, pentyl-, n-pentyl-, sec-pentyl-, 3-pentyl-, 2-methylbutyl-, iso-pentyl-, 3-methylbut-2-yl-, 2-methylbut-2-yl-, neopentyl-, hexyl-, heptyl-, octyl-, ethylhexyl- and 2-ethylhexyl-. In a particularly preferred embodiment, the crosslinker having an oxime residue is methyl-tris(2-pentanone oximo)silane, vinyl-tris(2-pentanone oximo)silane and / or tetra(2-pentanone oximo)silane.

[0084] In a further preferred embodiment of the present invention, in the carboxylic acid amide residue of the crosslinker according to the present invention, R i and R j are independently H or an optionally substituted straight or branched chain C1-C12 alkyl group, an optionally substituted C4-C10 cycloalkyl group, an optionally substituted C4-C10 aryl group, or an optionally substituted C5-C11 aralkyl group, in particular H or an optionally substituted straight or branched chain C1-C8 alkyl group, an optionally substituted C4-C8 cycloalkyl group, an optionally substituted C4-C10 aryl group, or an optionally substituted C5-C11 aralkyl group.

[0085] In the carboxylic acid amide residue of the crosslinker, R i and R jare preferably selected, independently of one another, from the group consisting of H, phenyl-, tolyl-, naphthyl-, benzyl-, cyclohexyl-, methyl-, ethyl-, propyl-, isopropyl-, butyl-, n-butyl-, sec-butyl-, iso-butyl-, tert-butyl-, pentyl-, n-pentyl-, sec-pentyl-, 3-pentyl-, 2-methylbutyl-, iso-pentyl-, 3-methylbut-2-yl-, 2-methylbut-2-yl-, neopentyl-, hexyl-, heptyl-, octyl-, ethylhexyl- and 2-ethylhexyl-. In a particularly preferred embodiment, the crosslinker having a carboxylic acid amide residue is methylethoxybis(N-methylbenzamido)silane.

[0086] In a further particularly preferred embodiment, a mixture of the crosslinking agents described is used in the curable composition according to the invention. In a further particularly preferred embodiment, the crosslinking agent is a mixture of the various residues R as described above. a Holds.

[0087] Additionally, the compositions according to the invention contain heterocyclic azasilanes which can function, inter alia, as adhesion promoters in the compositions. It is also possible to use mixtures of several heterocyclic azasilanes.

[0088] In a preferred embodiment, the heterocyclic azasilane has the formula: [ka] [In the formula, a=0, 1 or 2; n = 0 to 6; Each R K , R L , R M , R O , R P and R Qare independently H, or an optionally substituted straight or branched chain C1-C20 alkyl group, an optionally substituted straight or branched chain C2-C20 alkenyl group, an optionally substituted C3-C20 cycloalkyl group, an optionally substituted C4-C20 cycloalkenyl group, an optionally substituted straight, branched or cyclic C4-C20 alkynyl group, or an optionally substituted straight or branched chain C2-C20 heteroalkyl group, an optionally substituted straight, branched or cyclic C3-C20 heteroalkenyl group, or an optionally substituted C4-C14 aryl or heteroaryl group, or two residues R K , R L , R M , R O , R P and R Q together form a 5- to 8-membered ring] It is a compound represented by the formula:

[0089] (R P ) a AND Q ) 2-a The parameter a in the formula (1) is the residue R P Alkoxy residues for OR Q Here, a can assume a value between 0 and 2. When a=0, the corresponding heterocyclic organosilane has the residue R P Contains no ORs Q The parameter a can also be 1. In this case, one R P Residue and one OR Q The residue is directly bonded to the silicon atom of the heterocyclic organosilane. When a=2, OR Q R instead of residue P Only the residue is linked to the silicon atom.

[0090] The residue (R M ) nare directly related to the size of the ring, which is determined by the parameter n, where the number of possible residues on the ring atoms is also controlled by the value n. For example, for a six-membered ring, n=2 and the residues R c or R C The number of is adjusted according to 2. This means that each ring atom can carry one residue.

[0091] Heterocyclic azasilanes can have different residues on each ring atom, and each R in formula (III) K , R L , R M , R O , R P and R Q are each independently H, or an optionally substituted linear or branched C1-C20 alkyl group, an optionally substituted linear or branched C2-C20 alkenyl group, an optionally substituted C3-C20 cycloalkyl group, an optionally substituted C4-C20 cycloalkenyl group, an optionally substituted linear, branched or cyclic C4-C20 alkynyl group, an optionally substituted linear or branched C2-C20 heteroalkyl group, an optionally substituted linear, branched or cyclic C3-C20 heteroalkenyl group, or an optionally substituted C4-C14 aryl or heteroaryl group. Preferably, each R K , R L , R M , R O , R P and R Q are independently H, or an optionally substituted straight or branched chain C1-C10 alkyl group, an optionally substituted straight or branched chain C2-C10 alkenyl group, an optionally substituted straight or branched chain C2-C10 heteroalkyl group, an optionally substituted C3-C10 cycloalkyl group, or an optionally substituted C4-C8 aryl or heteroaryl group. K , R L , R M , R O , R Pand R Q are independently H, an optionally substituted straight or branched chain C1-C8 alkyl group, an optionally substituted straight or branched chain C2-C8 alkenyl group, an optionally substituted straight or branched chain C4-C8 heteroalkyl group, an optionally substituted C4-C6 cycloalkyl group, or an optionally substituted C5-C6 aryl or heteroaryl group.

[0092] n is preferably 1 to 4, more preferably 1 or 2, and particularly preferably 1.

[0093] In a preferred embodiment of the invention, the heterocyclic azasilane has the following structural formula: [ka]

[0094] The compositions according to the invention may contain one or more of the compounds set out above (heterocyclic azasilanes).

[0095] Particularly preferred heterocyclic azasilanes are substituted or unsubstituted, especially unsubstituted, Nn-butyl-1-aza-2,2-dimethoxy-2-silacyclopentane ((BDC), CAS No. 618914-44-6), 2,2-diethoxy-1-(3-triethoxysilylpropyl)aza-2-silacyclopentane ((TESPDC), CAS No. 1184179-50-7) and / or 2,2-diethoxy-1-(trimethylsilyl)aza-2-silacyclopentane ((TMS)DEC), CAS No. 21297-72-3).

[0096] In a preferred embodiment, the composition according to the invention contains the heterocyclic azasilane in an amount of 0.1 to 3 wt.%, preferably 0.2 to 2 wt.%, particularly preferably 0.3 to 1.5 wt.%, based on the total weight of the composition.

[0097] The composition according to the invention preferably additionally contains a metal catalyst to accelerate the curing of the composition according to the invention. Particularly preferably, the composition according to the invention contains a metal catalyst that does not contain tin. These catalysts are advantageous in that toxic tin is avoided. They solve the problem of the invention by avoiding toxic components of the composition, especially toxic tin. Surprisingly, in the context of the present invention, it has been found that although tin-containing catalysts are particularly effective catalysts in these silicone rubber compounds, even when tin-free catalysts are used in the mixture, the combination containing heterocyclic azasilane and organic phosphonic acid in the presence of polyorganosiloxane and crosslinker can provide a curable composition with the advantage of increased storage stability and more rapid crosslinking occurs. In this way, the advantage of increased storage stability can be combined with the low toxicity of tin-free catalysts, while simultaneously retaining other advantageous properties of the curable composition.

[0098] Preferably, the metal of the metal catalyst is selected from the group consisting of Na, Zn, Sc, Nd, Ti, Zr, Hf, V, Fe, Pt, Cu, Ga, and Bi, more preferably, selected from the group consisting of Zn, Ti, Zr, Hf, V, Fe, and Bi, and most preferably, the metal of the metal catalyst is Zr.

[0099] In a preferred embodiment of the present invention, the composition comprises, as the metal catalyst, a metal siloxane, in particular a compound represented by the formula R * A S B O C M D [In the formula, Each R * is independently selected from the group consisting of optionally substituted C1-C20 alkyl, optionally substituted C3-C6 cycloalkyl, optionally substituted C2-C20 alkenyl, optionally substituted C6-C10 aryl, -OH, and -O-(C1-C20 alkyl); M is a metal, A is an integer from 4 to 19, B is an integer from 4 to 10; C is an integer from 8 to 30, and D is an integer from 1 to 8. The metal siloxane includes a metal siloxane represented by the formula:

[0100] The metal siloxane is preferably a metal silsesquioxane, in particular a polyhedral metal silsesquioxane, which is understood to be a metal silsesquioxane in which the silicon and metal atoms at least partially occupy the corners of a polyhedron, for example a cube.

[0101] The metal silsesquioxanes are particularly preferably polyhedral titanium and / or zirconium silsesquioxanes, especially zirconium silsesquioxane.

[0102] In a preferred embodiment, the metal siloxane, preferably a metal silsesquioxane, has the following formula (IV): [ka] [In the formula, X 1 , X 2 and X 3 are independently Si or M 1 where M 1 is a metal, preferably a metal other than tin, in particular from the group consisting of Na, Zn, Sc, Nd, Ti, Zr, Hf, V, Fe, Pt, Cu, Ga and Bi; particularly preferably from the group consisting of Zn, Ti, Zr, Hf, V, Fe and Bi, Z 1 , Z 2 and Z 3 are independently, L 2 , R 5 , R 6 and R 7 wherein L is selected from the group consisting of 2 is selected from the group consisting of -OH and -O-(C1-C10 alkyl), in particular -O-(C1-C8 alkyl) or -O-(C1-C6 alkyl), or L 2is selected from the group consisting of -OH, -O-methyl, -O-ethyl, -O-propyl, -O-butyl, -O-octyl, -O-isopropyl, and -O-isobutyl; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are independently selected from the group consisting of optionally substituted C1-C20 alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted C2-C20 alkenyl, and optionally substituted C5-C10 aryl; Y 1 and Y 2 are independently, -OM 2 -L 3 Δ or Y 1 and Y 2 Together, -OM 2 (L 3 Δ )-O- or -O-, where L 3 is selected from the group consisting of -OH and -O-(C1-C10 alkyl), in particular -O-(C1-C8 alkyl) or -O-(C1-C6 alkyl), or L 3 is selected from the group consisting of -OH, -O-methyl, -O-ethyl, -O-propyl, -O-butyl, -O-octyl, -O-isopropyl, and -O-isobutyl, and M 2 is a metal, preferably a metal other than tin, more preferably from the group consisting of Na, Zn, Sc, Nd, Ti, Zr, Hf, V, Fe, Pt, Cu, Ga and Bi; particularly preferably from the group consisting of Zn, Ti, Zr, Hf, V, Fe, Bi, and X 4 -M 3 L 1 Δ or M 3 And Q 1 and Q 2 are H or M, respectively. 3where L is a single bond connected to 1 is selected from the group consisting of -OH and -O-(C1-C10 alkyl), in particular -O-(C1-C8 alkyl) or -O-(C1-C6 alkyl), or L 1 is selected from the group consisting of -OH, -O-methyl, -O-ethyl, -O-propyl, -O-butyl, -O-octyl, -O-isopropyl, and -O-isobutyl, and M 3 is a metal, preferably a metal other than tin, more preferably a metal selected from the group consisting of Na, Zn, Sc, Nd, Ti, Zr, Hf, V, Fe, Pt, Cu, Ga and Bi; particularly preferably a metal selected from the group consisting of Zn, Ti, Zr, Hf, V, Fe, Bi, or X 4 -M 3 L 1 And Q 2 is H or M 3 is a single bond connected to Q 1 , H, M 4 L 4 Δ or -SiR 8 where M 4 is a metal, preferably a metal other than tin, more preferably a metal selected from the group consisting of Na, Zn, Sc, Nd, Ti, Zr, Hf, V, Fe, Pt, Cu, Ga and Bi; particularly preferably a metal selected from the group consisting of Zn, Ti, Zr, Hf, V, Fe and Bi, and L 4 is selected from the group consisting of -OH and -O-(C1-C10 alkyl), in particular -O-(C1-C8 alkyl) or -O-(C1-C6 alkyl), or L 4 is selected from the group consisting of -OH, -O-methyl, -O-ethyl, -O-propyl, -O-butyl, -O-octyl, -O-isopropyl, and -O-isobutyl, and R 8 is selected from the group consisting of optionally substituted C1-C20 alkyl, optionally substituted C3-C6 cycloalkyl, optionally substituted C2-C20 alkenyl, and optionally substituted C6-C10 aryl; or X 4 , Q 1 and Q 2 are, independently of each other, -M 3 L 1 Δ or X 4 is -Si(R 8 )-OM 3 L 1 Δ And Q 2 X 4 is a single bond connected to the Si atom of Q 1 -M 4 L 4 Δ or X 4 is -Si(R 8 )-OM 3 L 1 Δ And Q 2 X 4 is a single bond connected to the Si atom of Q 1 X 4 M 3 is a single bond connected to the atom. has.

[0103] In particularly preferred embodiments, the metal silsesquioxane has structural formula (V): [ka] [In the formula, X 1 , X 2 and X 3 are independently Si or M 1 where M 1 is a metal, preferably a metal other than tin, more preferably a metal selected from the group consisting of Na, Zn, Sc, Nd, Ti, Zr, Hf, V, Fe, Pt, Cu, Ga and Bi; more preferably a metal selected from the group consisting of Zn, Ti, Zr, Hf, V, Fe and Bi, Z 1 , Z 2 and Z 3 are independently, L2 , R 5 , R 6 and R 7 wherein L is selected from the group consisting of 2 is selected from the group consisting of -OH and -O-(C1-C10 alkyl), in particular -O-(C1-C8 alkyl) or -O-(C1-C6 alkyl), or L 2 is selected from the group consisting of -OH, -O-methyl, -O-ethyl, -O-propyl, -O-butyl, -O-octyl, -O-isopropyl, and -O-isobutyl; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are independently selected from the group consisting of optionally substituted C1-C20 alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted C2-C20 alkenyl, and optionally substituted C5-C10 aryl; X 4 -M 3 L 1 Δ where L 1 is selected from the group consisting of -OH and -O-(C1-C10 alkyl), in particular -O-(C1-C8 alkyl) or -O-(C1-C6 alkyl), or L 1 is selected from the group consisting of -OH, -O-methyl, -O-ethyl, -O-propyl, -O-butyl, -O-octyl, -O-isopropyl, and -O-isobutyl, and M 3 is a metal, preferably a metal other than tin, more preferably a metal selected from the group consisting of Na, Zn, Sc, Nd, Ti, Zr, Hf, V, Fe, Pt, Cu, Ga and Bi; particularly preferably a metal selected from the group consisting of Zn, Ti, Zr, Hf, V, Fe and Bi. has.

[0104] In another particularly preferred embodiment, the metal silsesquioxane has the formula (VI): [ka] [In the formula, X 4 -M 3 L 1 Δ where L 1 is selected from the group consisting of -OH and -O-(C1-C10 alkyl), in particular -O-(C1-C8 alkyl) or -O-(C1-C6 alkyl), or L 1 is selected from the group consisting of -OH, -O-methyl, -O-ethyl, -O-propyl, -O-butyl, -O-octyl, -O-isopropyl, and -O-isobutyl, and M 3 is a metal, preferably a metal other than tin, more preferably a metal selected from the group consisting of Na, Zn, Sc, Nd, Ti, Zr, Hf, V, Fe, Pt, Cu, Ga and Bi; particularly preferably a metal selected from the group consisting of Zn, Ti, Zr, Hf, V, Fe and Bi, Z 1 , Z 2 and Z 3 are independently selected from the group consisting of optionally substituted C1-C20 alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted C2-C20 alkenyl, and optionally substituted C5-C10 aryl; R 1 , R 2 , R 3 and R 4 are each independently selected from the group consisting of optionally substituted C1-C20 alkyl, optionally substituted C3-C8 cycloalkyl, optionally substituted C2-C20 alkenyl, and optionally substituted C5-C10 aryl. has.

[0105] Particularly preferred in the above formula is X 4=ZrOR or TiOR, especially ZrOR (where R = C1-C12 alkyl), especially ZrO-methyl, ZR-O-ethyl, ZR-O-propyl, ZR-O-butyl, ZR-O-octyl, ZR-O-isopropyl, ZR-O-isobutyl, ZR-O-butyl.

[0106] In a particularly preferred embodiment, the metal silsesquioxane has the structure (VII): [ka] [In the formula, Zr is linked to OR, where R is selected from the group consisting of -H, -methyl, -ethyl, -propyl, -butyl, -octyl, -isopropyl, and -isobutyl; Z 1 , Z 2 and Z 3 are each independently selected from the group consisting of C1-C20 alkyl, C3-C8 cycloalkyl, C2-C20 alkenyl and C5-C10 aryl, in particular methyl, ethyl, propyl, isopropyl, butyl, isobutyl, hexyl, heptyl, octyl, vinyl, allyl, butenyl and phenyl, and benzyl; and R 1 , R 2 , R 3 and R 4 are each independently C1-C20 alkyl, C3-C8 cycloalkyl, C2-C20 alkenyl and C5-C10 aryl, in particular selected from the group consisting of methyl, ethyl, propyl, isopropyl, butyl, isobutyl, hexyl, heptyl, octyl, vinyl, allyl, butenyl and phenyl, as well as benzyl. has.

[0107] The weight ratio of polyorganosiloxane (a), in particular the α,ω-dihydroxyl terminated polydialkylsiloxane, to crosslinker is preferably from 100:1 to 2:1, particularly preferably from 50:1 to 5:1, in particular from 15:1 to 6:1.

[0108] In addition to the components mentioned, the compositions according to the invention may optionally contain further raw materials / ingredients, in particular conventional additives such as fillers, plasticizers, reactive diluents, colorants, thixotropic agents, rheological additives, wetting agents, UV stabilizers, antioxidants, drying agents, etc. Preferably, the curable compositions according to the invention contain at least one further ingredient.

[0109] The composition according to the invention may preferably contain a plasticizer. Preferred plasticizers are end-capped polyethylene glycols, such as polyethylene or polypropylene glycol dialkyl ethers (where the alkyl residues have 1 to 4 C atoms), in particular the dimethyl and diethyl ethers of diethylene glycol and dipropylene glycol. Preferred plasticizers are also diurethanes, which can be produced, for example, by reacting diols with OH end groups with monofunctional isocyanates. In a preferred embodiment of the invention, polyalkylsiloxanes, particularly preferably polydimethylsiloxanes, are used as plasticizers.

[0110] The curable composition preferably contains plasticizers in an amount of 2 to 50 wt.%, preferably in an amount of 10 to 40 wt.%, particularly preferably in an amount of 20 to 35 wt.%, in each case based on the total weight of the composition. If a mixture of several plasticizers is used, the amounts given refer to the total amount of plasticizer in the composition.

[0111] Reactive diluents can also be added if they reduce the viscosity of the curable composition. Suitable reactive diluents are compounds that are miscible with the composition and have at least one group reactive with the polymer. Preferably, the reactive diluent has at least one functional group that reacts with moisture or atmospheric oxygen. Examples are unsaturated groups such as isocyanate groups, silyl groups, or vinyl groups. To produce a preferred reactive diluent, for example, the corresponding polyol component can be reacted with at least a difunctional isocyanate.

[0112] The composition according to the invention may further contain a filler.Suitable fillers include chalk, limestone powder, precipitated and / or fumed silica, zeolite, bentonite, magnesium carbonate, alumina, tallow, titanium oxide, iron oxide, zinc oxide, quartz, sand, mica and other powdered or crushed minerals.In addition, organic fillers can also be used, in particular wood fiber, wood flour, wood chips, cellulose, cotton, rice husk.

[0113] In a particularly preferred embodiment of the invention, silica is added to the composition as a filler in untreated and / or treated form, preferably in hydrophobized form, particularly preferably in fumed silica, also called fumed silicon dioxide. In a particularly preferred embodiment of the invention, a mixture of untreated silica and hydrophobized silica is added to the hardenable composition as a filler.

[0114] The fillers are preferably used in an amount of 1 to 60 wt.%, particularly preferably 2 to 20 wt.%, very particularly preferably 5 to 15 wt.%, in each case based on the total weight of the composition. It is also possible to use mixtures of several fillers. In this case, the amounts given refer to the total amount of filler in the composition.

[0115] Depending on the application, additives or fillers that impart thixotropic properties to the formulation are preferred. Such fillers are also described as rheological auxiliaries, for example hydrogenated castor oil, fatty acid amides or swellable plastics.

[0116] In addition to the heterocyclic azasilane, the composition according to the present invention may contain an additional adhesion promoter.Suitable adhesion promoters here are, for example, resins, such as aliphatic or petrochemical resins and modified phenolic resins and terpene oligomers.Such resins are used, for example, as adhesion promoters for pressure-sensitive adhesives and coatings.Terpene-phenolic resins are also suitable.

[0117] Preferably, the curable composition contains at least one stabilizer selected from the group consisting of antioxidants, UV stabilizers and desiccant. The antioxidant is preferably present at up to about 6 wt.%, in particular at up to about 4 wt.%. In the context of the present invention, it is preferred if a UV stabilizer is used that carries a silyl group and polymerizes into a product during crosslinking or curing.

[0118] In addition, the composition according to the invention can be stabilized against the penetration of moisture by means of a desiccant, in order to further improve the shelf life.All compounds that react with water to form inert groups with respect to the reactive groups present in the preparation are suitable as desiccant.Suitable desiccant includes isocyanates and silanes, such as vinylanes, for example 3-vinylpropyltriethoxysilane, oximosilanes or carbamatosilanes.However, it is also possible to use methyl, ethyl or vinyltrimethoxysilane, tetramethyl or ethylethoxysilane.Vinyltrimethoxysilane and tetraethoxysilane are particularly preferred.

[0119] In a preferred embodiment of the invention, the components of the composition are mixed together, in particular in the form of a single-phase mixture.

[0120] The present invention also relates to a process for preparing the curable composition according to the present invention, in which components (a)-(d) and optionally other components are mixed together.

[0121] The invention also relates to the use of the curable compositions according to the invention, in particular as sealants, glues, coatings, joint compounds, casting compounds, adhesives and / or in paints.

[0122] It is understood that the features mentioned above and those described below can be used not only in the specified combinations, but also in other combinations or by themselves, without going beyond the scope of the invention. The advantages of the above features or combinations of several features are merely exemplary and may take effect alternatively or cumulatively. The combination of features of different embodiments of the invention or features of different claims may deviate from the selected references of the claims.

[0123] The following examples further illustrate the invention without, however, limiting it thereto. EXAMPLES

[0124] Example 1: Silicone rubber compounds are produced according to the following recipe: 570g of alpha-omega-hydroxyl terminated polydimethylsiloxane with a viscosity of 80,000 cSt 270 g of polydimethylsiloxane with a viscosity of 100 cSt Untreated highly dispersed silica 50g Hydrophobized highly dispersed silica 50g A mixture of 40.7 g of methyl-tris(ethyllactato)silane and 8.7 g of tetraethyllactatosilane Adhesion promoter Butyldimethoxycyclosilane (BDC, Nn-butyl-1-aza-2,2-dimethoxy-2-silacyclopentane) 12.0g Catalyst iBu-POSS-Zr-Oet 0.5g Octylphosphonic acid 1.5g

[0125] The sealant was exposed to air after application: - Film formation time: 5 minutes - Bonding time 35 minutes - Initial stress after 180 minutes -Fully cured after 24 hours - Transparent appearance -Shore hardness A 18 -Good adhesion to wood, painted wood, varnished wood, aluminium, powder coated aluminium, glass, PVC, polyamide, steel, concrete etc.

[0126] The sealant is also characterized by its excellent storage stability.

[0127] After 8 weeks of storage at 50° C. in the cartridge, the sealant still has the same properties as when first applied.

[0128] Example 2: The silicone rubber compound is produced according to the following formula: 570g of alpha-omega-hydroxyl terminated polydimethylsiloxane with a viscosity of 80,000 cSt 270 g of polydimethylsiloxane with a viscosity of 100 cSt Untreated highly dispersed silica 50g Hydrophobized highly dispersed silica 50g Methyl-tris(ethyllactato)silane 49.4g Adhesion promoter Butyldimethoxycyclosilane (BDC, Nn-butyl-1-aza-2,2-dimethoxy-2-silacyclopentane) 12.0g Catalyst iBu-POSS-Zr-Oet 1.0g Octylphosphonic acid 1.5g

[0129] The sealant was exposed to air after application: - Film formation time: 11 minutes - Bonding time 65 minutes - Initial stress after 280 minutes -Fully cured after 24 hours - Transparent appearance -Shore hardness A 17 -Good adhesion to wood, painted wood, varnished wood, aluminium, powder coated aluminium, glass, PVC, polyamide, steel, concrete etc.

[0130] The sealant is also characterized by its excellent storage stability.

[0131] After 8 weeks of storage at 50° C. in the cartridge, the sealant still has the same properties as when first applied.

[0132] For detailed examination and comparison with established silicone sealants, the following Example 3 and Comparative Example were examined in detail.

[0133] Example 3 In a similar manner to Examples 1 and 2, a silicone rubber compound was prepared according to the following recipe: [Table 1]

[0134] Comparative Example (Prior Art) [Table 2]

[0135] The optical properties of the compositions from Examples 1-3 and Comparative Example were comparable with respect to application, as were the mechanical properties after curing. However, the silicone rubber compounds according to Examples 1-3 were found to have improved storage stability and adhesion compared to the Reference Example. The compositions according to Examples 1-3 remained colorless after 8 weeks of storage at 50°C, whereas the Comparative Example composition was yellowish after 8 weeks at 50°C. With respect to adhesion, the compositions according to Examples 1-3 showed improved adhesion to Plexiglas, polycarbonate and polystyrene compared to the Comparative Example. An additional advantage of the above examples according to the present invention is that toxic tin can be omitted.

[0136] Compared to the comparative sealants above, the above examples show that the mechanical properties of the compositions according to the invention are equally good compared to known silicone rubber compounds, while the storage stability and adhesion to plastics such as plexiglass, polycarbonate or polystyrene can be improved.

Claims

1. (a) Formula HO-(SiR l R m O) o -H[where, Each R l and R m are, independently, optionally substituted alkyl, alkenyl or alkynyl residues; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue; and o is an integer from 5 to 5000. A polyorganosiloxane represented by the formula: (b) Formula Si (R) m (R a ) 4-m [In the formula, Each R is independently optionally substituted alkyl, alkenyl or alkynyl residues; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue; m is an integer from 0 to 2, and each R a are, independently, (b1) Formula (I): 【Chemistry 15】 (In the formula, Each R b and R c are, independently of each other, hydrogen; optionally substituted alkyl, alkenyl or alkynyl residues; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue; Each R d are, independently, optionally substituted alkyl, alkenyl or alkynyl residues; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue; Each R e are, independently, carbon; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue; and n is an integer from 1 to 10. A hydroxycarboxylic acid ester residue represented by the formula: (b2) Formula (II): 【Chemistry 16】 (In the formula, Each R n , R o , R p and R q are, independently of each other, hydrogen; optionally substituted alkyl, alkenyl or alkynyl residues; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue; R r are, independently of each other, carbon; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue; and p is an integer from 1 to 10. a hydroxycarboxamide residue represented by (b3) Carboxylic acid residue -O-C(O)-R f , (b4) Oxime residue -O-N=CR g R h , and (b5) Carboxylic acid amide residue -N(R i )-C(O)-R j , (In the formula, each R f , R g , R h , R i and R j are, independently of each other, hydrogen; optionally substituted alkyl, alkenyl or alkynyl residues; an optionally substituted alicyclic, aryl or aralkyl residue; or represents an optionally substituted heteroalicyclic or heteroaryl residue selected from the group consisting of A crosslinking agent represented by the formula: (c) heterocyclic azasilanes, in which N and Si are ring atoms and are directly linked to each other; and (d) R-PO (OH) 2 [In the formula, R is optionally substituted alkyl, alkenyl or alkynyl residues, an optionally substituted alicyclic, aryl or aralkyl residue, or is an optionally substituted heteroalicyclic or heteroaryl residue. A curable composition comprising an organic phosphonic acid represented by the formula:

2. 2. The composition according to claim 1, characterized in that the amount of said organic phosphonic acid based on the total amount of said crosslinker is 0.3 to 30 mol %, preferably 1 to 10 mol %.

3. 3. The composition according to claim 1, characterized in that the organic phosphonic acid is an alkylphosphonic acid having from 2 to 12 carbon atoms, preferably octylphosphonic acid.

4. The composition according to any one of claims 1 to 3, characterized in that it additionally comprises a metal catalyst, preferably a tin-free metal catalyst.

5. 5. The composition of claim 4, characterized in that the metal of the metal catalyst is selected from the group consisting of Na, Zn, Sc, Nd, Ti, Zr, Hf, V, Fe, Pt, Cu, Ga, and Bi, preferably selected from the group consisting of Zn, Ti, Zr, Hf, V, Fe, and Bi.

6. 6. The composition according to claim 4 or 5, characterized in that the metal of the metal catalyst is Zr.

7. The metal catalyst has the formula: R * A Si B O C M D [In the formula, Each R * is independently selected from the group consisting of optionally substituted C1-C20 alkyl, optionally substituted C3-C6 cycloalkyl, optionally substituted C2-C20 alkenyl, optionally substituted C6-C10 aryl, -OH, and -O-(C1-C20 alkyl); M is the metal; A is an integer from 4 to 19, B is an integer from 4 to 10, C is an integer from 8 to 30, and D is an integer from 1 to 8.

7. The composition according to claim 4, which is a metal siloxane represented by the formula:

8. 8. The composition according to claim 7, characterized in that the metal siloxane is a polyhedral metal silsesquioxane, in particular a polyhedral titanium and / or zirconium silsesquioxane.

9. In the crosslinking agent, each R a But independently, (b1) a hydroxycarboxylic acid ester residue of formula (I), the residue being as defined in claim 1, and (b2) a hydroxycarboxylic acid amide residue of formula (II), the residue being as defined in claim 1. The composition according to any one of claims 1 to 8, characterized in that it is selected from the group consisting of:

10. R of the crosslinking agent a The composition according to any one of claims 1 to 9, characterized in that is a hydroxycarboxylic acid ester residue represented by formula (I) (preferably, n = 1).

11. The heterocyclic azasilane has the formula: 【Chemistry 17】 [In the formula, a=0, 1 or 2; n=0 to 6; Each R K , R L , R M , R O , R P and R Q are independently H, or an optionally substituted linear or branched C1-C20 alkyl group, an optionally substituted linear or branched C2-C20 alkenyl group, an optionally substituted C3-C20 cycloalkyl group, an optionally substituted C4-C20 cycloalkenyl group, an optionally substituted linear, branched or cyclic C4-C20 alkynyl group, or an optionally substituted linear or branched C2-C20 heteroalkyl group, an optionally substituted linear, branched or cyclic C3-C20 heteroalkenyl group, or an optionally substituted C4-C14 aryl or heteroaryl group, or two residues R K , R L , R M , R O , R P and R Q together form a 5- to 8-membered ring. The composition according to any one of claims 1 to 10, characterized in that the compound is represented by the formula:

12. 12. Composition according to any one of claims 1 to 11, characterized in that the heterocyclic azasilane is N-n-butyl-1-aza-2,2-dimethoxy-2-silacyclopentane, 2,2-diethoxy-1-(3-triethoxysilylpropyl)aza-2-silacyclopentane and / or 2,2-diethoxy-1-(trimethylsilyl)aza-2-silacyclopentane, preferably N-n-butyl-1-aza-2,2-dimethoxy-2-silacyclopentane.

13. The composition according to any one of claims 1 to 12, characterized in that the polyorganosiloxane is a polydimethylsiloxane.

14. A process for preparing a curable composition according to any one of claims 1 to 13, characterized in that components (a) to (d) and optionally further components are mixed.

15. Use of the curable composition according to any one of claims 1 to 13 as a sealant, glue, coating, joint material, potting resin, adhesive or in a paint.

Citation Information

Patent Citations

  • Organopolysiloxane composition, method for producing the same, crosslinkable material made of the composition and molding made of the material

    JP2004197097A

  • moisture curable composition

    JP2016527344A

  • Composition for silicone rubber materials

    WO2020038950A1